A Win For Portola Pharmaceuticals, Inc.
Tue, May 05, 2020 at 05:30 PM
Portola Pharmaceuticals, Inc. (PTLA:NASDAQ) rocketted at $17.85, representing a gain of 130%. On Mon 04 May 20, PTLA:NASDAQ touched a New 2-Week High of $7.76. The stock appeared on our News Catalysts scanner on Sat 02 May 20 at 04:57 AM in the 'PRIVATE PLACEMENT' category. From Mon 20 Apr 20, the stock recorded 50.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About Portola Pharmaceuticals, Inc. (PTLA:NASDAQ)
Portola Pharmaceuticals Inc is engaged in the healthcare sector. It develops & commercializes novel therapeutics to combat thrombosis, hematologic disorders & inflammation.
Top 10 Gainers:
- Portola Pharmaceuticals, Inc. (PTLA:NASDAQ), 130.03%
- Ritter Pharmaceuticals, Inc. (RTTR:NASDAQ), 87.68%
- Genprex, Inc. (GNPX:NASDAQ), 51.52%
- DropCar, Inc. (DCAR:NASDAQ), 49.08%
- BioPharmX Corporation (BPMX:NYSEMKT), 39.43%
- Staffing 360 Solutions, Inc. (STAF:NASDAQ), 38.89%
- Adverum Biotechnologies, Inc. (ADVM:NASDAQ), 38.35%
- Conatus Pharmaceuticals Inc. (CNAT:NASDAQ), 38.27%
- Akebia Therapeutics, Inc. (AKBA:NASDAQ), 37.99%
- Lightbridge Corporation (LTBR:NASDAQ), 37.78%